Effectiveness of Ayurvedic Formulation for COVID 19
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/08/026978
- Lead Sponsor
- epal Health Research COuncil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Applicable
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age between 18 to 70 years
COVID-19 patients confirmed by RT-PCR testing within 4 days
Symptomatic COVID-19 patients with Mild to Moderate
Confirmed cases of COVID-19 in hospital with asymptomatic cases
Participation of the subject is voluntary
Exclusion Criteria
Children below 18 years
Immunocompromised patients (HIV, Cancer, etc.)
Co-morbid patients of HTN, COPD, Diabetes, Malignant tumour
Pregnant women
Severe or immediately life-threatening COVID-19 case
Surgery undergone within past 6 months
Patients of moderate to severe liver disease
Patients of chronic kidney disease
Drug Sensitivity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of the positive to Negative Conversion of SARS-COV2Timepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method Changes in the hematological parameters <br/ ><br>Changes in the immunological parameters <br/ ><br>Complications due to COVID 19Timepoint: one week, two weeks, three weeks and 4 weeks